Table 1.
Final pathological diagnosis of 453 adnexal masses
Pathologic diagnosis | No.(%) |
---|---|
Benign adnexal masses | 184 (40.62) |
Mature teratoma | 71 (15.67) |
Mucinous cystadenoma | 49 (10.82) |
Serous cystadenoma | 31 (6.84) |
Thecoma fibroma | 8 (1.77) |
Struma ovarii | 6 (1.32) |
Thecoma of the ovary | 5 (1.10) |
Fibroma | 4 (0.88) |
Serous adenofibroma | 2 (0.44) |
Brenner tumor | 2 (0.44) |
Endometrioid cyst | 2 (0.44) |
Microcystic stromal tumor | 1 (0.22) |
Wolffian tumor | 1 (0.22) |
Inclusion cyst | 1 (0.22) |
Mucinous adenofibroma | 1 (0.22) |
Malignant adnexal masses | 269 (59.38) |
Serous cystadenocarcinoma | 158 (34.88) |
Borderline mucinous cystadenoma | 28 (6.18) |
Borderline serous cystadenoma | 20 (4.42) |
Clear cell carcinoma | 15 (3.31) |
Metastatic carcinoma | 13 (2.87) |
Endometrioid carcinoma | 6 (1.32) |
Malignant Mullerian tube mixed tumor | 5 (1.10) |
Granular cell tumor | 4 (0.88) |
Mixed carcinoma | 4 (0.88) |
Mucinous cystadenocarcinoma | 3 (0.66) |
Ovarian dysgerminoma | 2 (0.44) |
Sertoli-Leydig cell tumor | 2 (0.44) |
Endometrioid borderline tumor | 2 (0.44) |
Yolk sac tumor | 2 (0.44) |
Immature teratoma | 2 (0.44) |
Adult granulose cell tumor of the ovary | 1 (0.22) |
Borderline Brenner Tumor | 1 (0.22) |
Small cell carcinoma of the ovary-hypercalcemic type | 1 (0.22) |
Data are given as n (%)